Author

Saeid Taghiloo

Observed name: Taghiloo, Saeid
ORCID: 0000-0002-8813-6046
Observed ORCID: 0000-0002-8813-6046
OpenAlex ID: A5070127280
2020 · Saeid Taghiloo, Hossein Asgarian-Omran · Critical Reviews in Oncology/Hematology · 93
2017 · Saeid Taghiloo, Esmaeil Allahmoradi, et al. · European Journal Of Haematology · 57
2019 · Sahar Tahaghoghi-Hajghorbani, Abolghasem Ajami, et al. · Autoimmunity Highlights · 35
2020 · Alireza Hejrati, Alireza Rafiei, et al. · Inflammopharmacology · 34
2017 · Esmaeil Allahmoradi, Saeid Taghiloo, et al. · PubMed · 31
2018 · Esmaeil Allahmoradi, Saeid Taghiloo, et al. · Medical Journal of the Islamic Republic of Iran · 30
2022 · Saeid Taghiloo, Saeid Norozi, et al. · Iranian Journal of Allergy Asthma and Immunology · 25
2024 · Saeid Taghiloo, Hossein Asgarian‐Omran · European Journal Of Haematology · 15
2021 · Saeid Taghiloo, Mohsen Soltanshahi, et al. · PubMed · 15
2023 · Saeid Taghiloo, Abolghasem Ajami, et al. · International Immunopharmacology · 12
2023 · Abbas Ranjbar, Mohsen Soltanshahi, et al. · Iranian journal of pharmaceutical research · 11
2022 · Mohsen Soltanshahi, Saeid Taghiloo, et al. · Iranian journal of pharmaceutical research · 11
2025 · Mohammad Malekan, Armin Dozandeh-Jouybari, et al. · Biochemistry and Biophysics Reports · 9
2023 · Saeid Taghiloo, Hossein Asgarian-Omran · Current Treatment Options in Oncology · 8
2022 · Mohammad Reza Haghshenas, Mahmood Moosazadeh, et al. · Iranian Journal of Public Health · 8
2025 · Mohammad Malekan, Saeid Taghiloo, et al. · Drug Discovery Today · 7
2020 · Saeid Taghiloo, Esmaeil Allahmoradi, et al. · Brazilian Journal of Pharmaceutical Sciences · 7
2025 · Armin Dozandeh-Jouybari, Erfan Rohaninia, et al. · Cancer Cell International · 4
Works count: 55
Citation count: 717
H-index: 15
I10-index: 18
Year
Topic
Type